Past Events

January 18, 2022 at 5:00 PM PST

Dr. Parren will present preclinical data on LAVA’s lead solid tumor Gammabody™ LAVA-1207 as well as new non-human primate data supporting the safety and tolerability profile of LAVA’s lead solid tumor Gammabody™ programs.

Presenter: Paul W.H.I. Parren, Ph.D., Executive Vice President, Head of Research and Development
Presentation Title: Bispecific Gamma-Delta T Cell Engagers Targeting PSMA for the Treatment of Prostate Cancer
Location: San Diego and virtual – Sapphire Session Room

November 29 - November 30, 2021
Virtual Presentation: Bispecific γδ T Cell Engagers for the Treatment of Cancer
Virtual Presentation Date/Time: Tues., Nov. 30, 2021 at 14:30 GMT
November 9 - November 11, 2021

Keynote Panel Discussion: Next generation antibody therapeutics: discovery, development and beyond
Panel Discussion Date/Time: Tues., Nov. 9, 2021 at 10:00 CET

Presentation: Bispecifics & Multispecifics Track – Bispecific gamma-delta T cell engagers
Presentation Date/Time: Tues., Nov. 9, 2021 at 14:00 CET

Session Chair: Bispecifics & Multispecifics Track
Session Date/Time: Tues., Nov. 9, 2021 at 15:40 CET